Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
BTG2 expression status correlated with survival of TNBC patients.
»
01/27/16
The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis
Altering fibroblast Tiam1 expression induces changes in invasion, migration, epithelial-mesenchymal transition.
»
01/28/16
Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations.
Bood correlation between the presence of an SDHB mutation, whether germline or sporadic, and negative SDHB IHC staining.
»
10/13/15
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.
Gene and protein expression of ABCG2/BCRP was up-regulated in the resistant sub-lines.
»
07/21/15
Knockdown of Legumain Suppresses Cervical Cancer Cell Migration and Invasion.
Legumain expression in HeLa and SiHa cells significantly reduced its migration and invasion abilities compared with control cells.
»
01/24/16
Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells.
FASN-mediated de novo lipid biosynthesis is closely associated with tumor growth and invasion in glioblastoma.
»
01/25/16
Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.
No significant difference between KRAS G13D and other KRAS MT tumours in terms of treatment benefit.
»
10/21/15
Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study.
Caffeinated coffee might have chemo-preventive effects against MM but not decaffeinated coffee.
»
01/25/16
miR-24 regulates CDKN1B/p27 expression in prostate cancer.
miR-24 expression was significantly lower in prostate cancer cell lines.
»
10/30/15
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
OvCa cell lines tested had detectable GR expression by Western blot and qRT-PCR analysis.
»
04/27/15
< Prev
Next >